Clinical Leader - Helping clinical research professionals connect and collaborate

Working hard for success-GettyImages-2201479298

Pharma Procurement Can Make Or Break Startups: Let's Help Mature Our Future Partners To Secure Innovation

To secure long-term innovation, Ascendis Pharma's Ivanna Rosendal suggests pharma companies should help startup companies through their growing pains.

GUEST COLUMNISTS

Want To Optimize Clinical Project Team Performance? Try This Formal 'Lessons Learned' Process
Learn how a formal "lessons learned" process can help teams work collaboratively with open, honest, and timely communication to reach thoughtful decisions that lead to on-time, on-budget, and inspection-ready trials.
4 Factors Changing The Way CRAs Monitor Trials
The way CRAs monitor is about to change. Regeneron's Patrick Floody discusses these four factors that will influence it.
How Can AI Change Computerized System Validation?
Learn how AI technologies are changing the computer system validation (CSV) landscape and what you need to understand about this transformation.
Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites
Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.
Will New AI Health Assistants Suggest Clinical Trials To Inquiring Patients?
New AI health assistants are now doing even more to help patients make sense of symptoms, diagnoses, and treatment options. What does that mean for the discoverability of clinical trials?
What CROs Do Right Isn't Always Obvious To Research Sites
CROs are doing many things right. But it's when that right thing is understood — not just executed — that the impact becomes far greater than compliance alone.
How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials
VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.
3 Clinical Research Attorneys Talk 2026 Trends
Three life sciences legal experts share what they see happening in the year ahead — and what should remain firmly in the past.

CLINICAL TRIAL WHITE PAPERS

Transforming Regulatory Processes Through AI, ML, NLP, And RPAs
Explore the rapidly evolving landscape of regulatory processes as they undergo a profound digital transformation, highlighting how emerging technologies are reshaping traditional regulatory frameworks.

Breaking Through Barriers With Integrated Trial Optimization
5/9/2025

In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.
5 Essential Capabilities For Decentralized Clinical Trials
2/3/2025

Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.
A New, AI-Augmented Horizon For Safety And Pharmacovigilance
1/6/2026

Is your organization leveraging AI to maximize efficiency in safety and regulatory workflows? If not, explore how these technologies are slated to improve industry approaches in 2026.
GMP Compliance For Pharmaceuticals And Medical Devices
3/14/2025

Good Manufacturing Practice (GMP) ensures products meet quality standards for their intended use, which covers all aspects of production. Explore how Ideagen supports GMP compliance across nine titles.
The Future Of Regulatory Operations
6/3/2024

The pathway to enhancing reliability, compliance, and efficiency across lifecycle management will require embracing technology and process improvement if organizations want to achieve their goals.

More Clinical Trial White Papers

CLINICAL TRIAL APP NOTES & CASE STUDIES

Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
6/26/2025

A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
Patient Caregiver Network Improves Post-Seizure Trial Data
3/26/2024

Discover how a pharmaceutical CRO addressed concerns about seizure diary timing in a rare disease study, leveraging insights from Medable's Patient Community Network to optimize data collection.
Optimized Processes: A Guide To Lyophilization Cycle Development
6/25/2024

Review the essential phases of the lyophilization cycle — freezing, primary drying, and secondary drying — and critical success factors to achieve optimal product quality and stability.
RTSM And Clinical Drug Dispensation
7/16/2024

A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
How Optina Diagnostics Used EDC In Earlier Disease Detection
5/15/2024

Understand how Optina Diagnostics streamlined operations and achieved significant milestones by leveraging Castor's tools in its effort to revolutionize the diagnostic process for Alzheimer’s.
GxP Inventory Delivers Real-Time Visibility, Operational Efficiency
11/17/2025

Modernize your clinical supply chain to streamline global trial operations, ensure regulatory compliance, and deliver investigational therapies to patients efficiently and reliably.

More Clinical Trial App Notes & Case Studies

NEWSLETTER ARCHIVE

More Newsletters

RECRUITMENT AND DIVERSITY

This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.

Building Patient Trust In Research Through Connection Driven-Transparency

The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
Patient Trust In Pharma Is Low; Here's How To Rebuild It

CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
The U.S. Trial Advantage Is Eroding

Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

FOCUS ON PATIENTS

Building Patient Trust In Research Through Connection Driven-Transparency

The question is not whether trust matters but how industry, sponsors, and investigators can bridge the trust gap to drive patient participation.
Patient Trust In Pharma Is Low; Here's How To Rebuild It

CISCRP's Annick de Bruin and Shalome Sine provide strategies for building patient trust based on the findings from their Perceptions & Insights Study.
How Gilead Includes Patients Most Affected By HIV In Its PrEP Trials

VP of Clinical Development, HIV, Moupali Das shares how the sponsor approaches diverse participant recruitment and enrollment, highlighting the importance of early demographic research and careful, intentional PI selection.